Back to Treatments

Treatment

Alpha-1 Antitrypsin Augmentation Therapy

1
Conditions
12
Trials
5,000
Participants
70%
Average Safety

Condition Evidence

Emphysema

12 trials · 5,000 participants

55% effectiveness · 70% safety
Alpha-1 Antitrypsin Augmentation Therapy | DFDA